Viewing Study NCT00087802


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-02-10 @ 5:29 AM
Study NCT ID: NCT00087802
Status: COMPLETED
Last Update Posted: 2009-04-16
First Post: 2004-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords: